Market revenue in 2022 | USD 129.2 million |
Market revenue in 2030 | USD 250.7 million |
Growth rate | 8.6% (CAGR from 2022 to 2030) |
Largest segment | Dermal fillers |
Fastest growing segment | Ophthalmic |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux |
Key market players worldwide | Allergan, Sanofi SA, Anika Therapeutics Inc, Bausch Health Companies Inc, Roche Holding AG ADR, Nestle SA, Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Ferring, Lifecore Biomedical Inc, Shiseido Co Ltd, Bloomage BioTechnology, LG Chem, Maruha Nichiro Corp, Genzyme, Seikagaku, HTL Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hyaluronic acid market will help companies and investors design strategic landscapes.
Dermal fillers was the largest segment with a revenue share of 55.8% in 2022. Horizon Databook has segmented the Brazil hyaluronic acid market based on dermal fillers, osteoarthritis, ophthalmic, vesicoureteral reflux covering the revenue growth of each sub-segment from 2017 to 2030.
Brazil ranked second in the total number of nonsurgical cosmetic procedures in 2020, as per ISAPS. There was a total of 6,011 plastic surgeons in Brazil in 2020, which is the second highest in the world. Moreover, hyaluronic acid procedures are the second most commonly performed nonsurgical esthetic procedures in Brazil.
A total of 165,707 hyaluronic acid procedures were performed in 2020. Increasing demand for anti-aging treatments, high awareness about esthetic procedures among women, and growing medical tourism are factors anticipated to fuel market growth in Brazil.
There are around 1.4 million women and 0.6 million men aged over 50 suffering from osteoporosis in the country. According to International Osteoporosis Foundation, private insurers do not reimburse osteoporosis medications, whereas government insurers reimburse some of the dispensed osteoporosis medications.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil hyaluronic acid market , including forecasts for subscribers. This country databook contains high-level insights into Brazil hyaluronic acid market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account